Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.

Breast Cancer Res Treat 2013 Dec 20;142(3):611-8. Epub 2013 Nov 20.

Centre for Health Informatics, Institute of Population Health, The University of Manchester, Jean McFarlane Building, Oxford Road, Manchester, M13 9PL, UK.

The aim of this study was to establish if risk-reducing surgery (RRS) increases survival among BRCA1/2 carriers without breast/ovarian cancer at the time of family referral. Female BRCA1/2 carriers were identified from the Manchester Genetic Medicine Database. Those patients alive and unaffected at the date of first family ascertainment were included in this study. Female first-degree relatives (FDRs) without predictive genetic testing who otherwise met eligibility criteria were also included. The effect of breast and ovarian RRS on survival was analysed. The survival experiences of RRS and non-RRS patients, stratified by BRCA status, were examined with Kaplan-Meier curves and contrasted using log-rank tests and Cox models. 691 female BRCA1/2 mutation carriers without breast or ovarian cancer at time of family ascertainment were identified; 346 BRCA1 and 345 BRCA2. 105 BRCA1 carriers and 122 BRCA2 carriers developed breast cancer during follow-up. The hazard of death was statistically significantly lower (P < 0.001) following RRS versus no RRS. 10-year survival for women having RRS was 98.9 % (92.4-99.8 %) among BRCA1 and 98.0 % (92.2-99.5 %) among BRCA2 carriers. This survival benefit with RRS remained significant after FDRs were added. Women who had any form of RRS had increased survival compared to those who did not have RRS; a further increase in survival was seen among women who had both types of surgery. However, formal evidence for a survival advantage from bilateral mastectomy alone requires further research.

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-013-2765-x
Publisher Site
http://dx.doi.org/10.1007/s10549-013-2765-xDOI Listing
December 2013
1 Read

Publication Analysis

Top Keywords

time family
12
survival
9
rrs
9
brca1/2 carriers
8
family referral
8
cancer time
8
female brca1/2
8
survival women
8
brca2 carriers
8
family ascertainment
8
mutation carriers
8
breast ovarian
8
survival brca1/2
8
increases survival
8
brca1/2 mutation
8
risk-reducing surgery
8
carriers
7
stratified brca
4
compared rrs
4
rrs 10-year
4

References

(Supplied by CrossRef)

D Schrag et al.
N Engl J Med 1997

AW Kurian et al.
J Clin Oncol 2012

BM Sigal et al.
Cancer Epidemiol Biomarkers Prev 2012

LM Byrd et al.
Cancer Epidemiol Biomarkers Prev 2008

SM Domchek et al.
JAMA 2010

S Domchek et al.
Lancet Oncol 2006

P Moller et al.
Int J Cancer 2002

TR Rebbeck et al.
N Engl J Med 2002

DG Evans et al.
Eur J Hum Genet 2009

DGR Evans et al.
J Med Genet 2009

Similar Publications